10 September 2020

Nanoparticles as a formulation platform for bioavailability-challenged molecules

Our Chief Technology Officer, Pascale Clement, spoke at the Formulation & Delivery Series UK virtual event on July 8 2020 to provide delegates with an overview of nanoparticles as a formulation platform for bioavailability-challenged molecules, highlighting the benefits of leon’s proprietary technology in characterisation and rapid scale-up from bench to clinic.

More articles

Nanotechnology: A pathway for sustainable innovation in drug development

It seems every effort to go green requires some sort of compromise whether that be price, performance, stability; whatever. Right now, electric cars are more expensive to buy than those with a conventional combustion engine. And they can’t go anywhere...